Hosted on MSN
How glycoprotein GP38 from Crimean-Congo hemorrhagic fever virus could advance monoclonal antibody therapies
A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute of Infectious Diseases, in collaboration with scientists from the Albert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results